Let’s start up with the current stock price of Cassava Sciences Inc. (SAVA), which is $47.93 to be very precise. The Stock rose vividly during the last session to $50.39 after opening rate of $47.82 while the lowest price it went was recorded $46.70 before closing at $49.64.Recently in News on December 23, 2021, Cassava Sciences Launches Clinical Website to Support Phase 3 Studies of Oral Simufilam in Alzheimer’s Disease. New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants. You can read further details here
Cassava Sciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $55.00 on 01/05/22, with the lowest value was $43.50 for the same time period, recorded on 01/03/22.
Cassava Sciences Inc. (SAVA) full year performance was 506.85%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cassava Sciences Inc. shares are logging -67.21% during the 52-week period from high price, and 494.66% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.06 and $146.16.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1070025 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Cassava Sciences Inc. (SAVA) recorded performance in the market was 13.59%, having the revenues showcasing -4.32% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.03B, as it employees total of 11 workers.
The Analysts eye on Cassava Sciences Inc. (SAVA)
During the last month, 4 analysts gave the Cassava Sciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 54.08, with a change in the price was noted -56.06. In a similar fashion, Cassava Sciences Inc. posted a movement of -53.87% for the period of last 100 days, recording 6,730,364 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SAVA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Cassava Sciences Inc. (SAVA)
Raw Stochastic average of Cassava Sciences Inc. in the period of last 50 days is set at 20.72%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 65.81%. In the last 20 days, the company’s Stochastic %K was 69.07% and its Stochastic %D was recorded 68.72%.
Considering, the past performance of Cassava Sciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 13.59%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -48.82%, alongside a boost of 506.85% for the period of the last 12 months. The shares increased approximately by 3.01% in the 7-day charts and went down by 12.56% in the period of the last 30 days. Common stock shares were lifted by -4.32% during last recorded quarter.